Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson for Stress Echocardiography
NCT00907764Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regadenoson in coronary artery disease (CAD), sponsored by Gilead Sciences. Started Apr 2009; status: terminated.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00907764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907764.